N/A
Manufactured by Acella Pharmaceuticals, LLC
87 FDA adverse event reports analyzed
Last updated: 2026-04-15
LEVOTHYROXINE, LIOTHYRONINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Acella Pharmaceuticals, LLC. The most commonly reported adverse reactions for LEVOTHYROXINE, LIOTHYRONINE include PRODUCT SUBSTITUTION ISSUE, FATIGUE, ASTHENIA, DIZZINESS, ARTHRALGIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LEVOTHYROXINE, LIOTHYRONINE.
Out of 15 classified reports for LEVOTHYROXINE, LIOTHYRONINE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 87 FDA FAERS reports that mention LEVOTHYROXINE, LIOTHYRONINE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include PRODUCT SUBSTITUTION ISSUE, FATIGUE, ASTHENIA, DIZZINESS, ARTHRALGIA, DISORIENTATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Acella Pharmaceuticals, LLC in connection with LEVOTHYROXINE, LIOTHYRONINE. Always verify the specific product and NDC with your pharmacist.